Literature DB >> 132719

Sponge matrix allografts. A model for analysis of killer cells infiltrating mouse allografts.

P J Roberts, P Häyry.   

Abstract

A method for isolation of allograft-infiltrating cells in a functionally viable state is described in this article. The method is based on the use of a spongious tissue into which cells of strain A (e.g., fibroblasts or tumor cells) are grown. The resulting graft is then transplanted to a strain B animal, and the infiltrating cells are released from it by gentle compression. The graft-infiltrating cells are completely recovered, and they may be processed for further experimentation and analysis by employing exclusively physical methods of cell preparation. As an example of future applications, some preliminary results on density- and charge fractionation of the graft-infiltrating cells are also reported.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 132719

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Implantation of a gelatin-sponge as a model for effector recruitment. Tumor growth inhibition by T-lymphocytes recovered from a site of tumor rejection.

Authors:  E T Akporiaye; M K Kudalore
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  An immobilized hybridoma culture perfusion system for production of monoclonal antibodies.

Authors:  A Lazar; L Silberstein; A Mizrahi; S Reuveny
Journal:  Cytotechnology       Date:  1988-11       Impact factor: 2.058

3.  Large agranular lymphocytes: early non-specific effector cells in allograft rejection in the mouse.

Authors:  C D Gregory; M E Atkinson
Journal:  Immunology       Date:  1984-10       Impact factor: 7.397

4.  A gelatin sponge model for studying tumor growth: quantitation of tumor cells and leukocytes in the CHO tumor.

Authors:  E T Akporiaye; G C Saunders; P M Kraemer
Journal:  Experientia       Date:  1987-06-15

5.  Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response.

Authors:  K L Buchanan; J W Murphy
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.